Marliolide inhibits skin carcinogenesis by activating NRF2/ARE to induce heme oxygenase-1

被引:21
作者
Lee, June
Mailar, Karabasappa
Yoo, Ok-Kyung
Choi, Won Jun [1 ]
Keum, Young-Sam [1 ]
机构
[1] Dongguk Univ, Coll Pharm, 32 Dongguk Ro, Goyang 10326, Gyeonggi Do, South Korea
基金
新加坡国家研究基金会;
关键词
ASYMMETRIC-SYNTHESIS; OXIDATIVE STRESS; PATHWAY; CANCER; MECHANISMS; TARGET; INJURY;
D O I
10.1016/j.ejmech.2018.02.068
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Heme oxygenase-1 (HO-1) catalyzes the enzymatic degradation of heme to produce three anti-oxidant molecules: carbon monoxide (CO), ferrous ion (Fe2+), and biliverdin. Induction of HO-1 is currently considered as a feasible strategy to treat oxidative stress-related diseases. In the present study, we identified marliolide as a novel inducer of HO-1 in human normal keratinocyte HaCaT cells. Mechanism based studies demonstrated that the induction of HO-1 by marliolide occurred through activation of NRF2/ARE via direct binding of marliolide to KEAP1. Structure-activity relationship revealed chemical moieties of marliolide critical for induction of HO-1, which renders a support for Michael reaction as a potential mechanism of action. Finally, we observed that marliolide significantly inhibited the papilloma formation in DMBA/TPA-induced mouse skin carcinogenesis model and this event was closely associated with lowering the formation of 8-OH- G and 4-HNE in vivo. Together, our study provides the first evidence that marliolide might be effective against oxidative stress-related skin disorders. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:113 / 126
页数:14
相关论文
共 26 条
[1]   Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents [J].
Abed, Dhulfiqar Ali ;
Goldstein, Melanie ;
Albanyan, Haifa ;
Jin, Huijuan ;
Hu, Longqin .
ACTA PHARMACEUTICA SINICA B, 2015, 5 (04) :285-299
[2]   Heme oxygenase-1: emerging target of cancer therapy [J].
Chau, Lee-Young .
JOURNAL OF BIOMEDICAL SCIENCE, 2015, 22
[3]   Therapeutic Potential of Heme Oxygenase-1/carbon Monoxide System Against Ischemia-Reperfusion Injury [J].
Cheng, Yuanyuan ;
Rong, Jianhui .
CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (26) :3884-3898
[4]   Chemical constituents of two Mollinedia species [J].
Claros, BMG ;
da Silva, AJR ;
Vasconcellos, MLAA ;
de Brito, APP ;
Leitao, GG .
PHYTOCHEMISTRY, 2000, 55 (07) :859-862
[5]   Inducers of heme oxygenase-1 [J].
Ferrandiz, M. L. ;
Devesa, I. .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (05) :473-486
[6]   Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis [J].
Fox, Robert J. ;
Miller, David H. ;
Phillips, J. Theodore ;
Hutchinson, Michael ;
Havrdova, Eva ;
Kita, Mariko ;
Yang, Minhua ;
Raghupathi, Kartik ;
Novas, Mark ;
Sweetser, Marianne T. ;
Viglietta, Vissia ;
Dawson, Katherine T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (12) :1087-1097
[7]   The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer [J].
Kansanen, Emilia ;
Kuosmanen, Suvi M. ;
Leinonen, Hanna ;
Levonen, Anna-Liisa .
REDOX BIOLOGY, 2013, 1 (01) :45-49
[8]   Molecular and Chemical Regulation of the Keap1-Nrf2 Signaling Pathway [J].
Keum, Young-Sam ;
Choi, Bu Young .
MOLECULES, 2014, 19 (07) :10074-10089
[9]   Inflammation: Gearing the journey to cancer [J].
Kundu, Joydeb Kumar ;
Surh, Young-Joon .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2008, 659 (1-2) :15-30
[10]   Asymmetric Synthesis of α-Alkylidene-β-hydroxy-γ-butyrolactones via Enantioselective Tandem Michael-Aldol Reaction [J].
Lee, Sung Il ;
Jang, Jin Hee ;
Hwang, Geum-Sook ;
Ryu, Do Hyun .
JOURNAL OF ORGANIC CHEMISTRY, 2013, 78 (02) :770-775